The current status of breast cancer advances.

What is it about?

The promises for NGS in breast cancer are tremendous for increasing our understanding of the disease, to identify new treatment targets and to move towards genome-informed personalized medicine

Featured Image

Why is it important?

Progress is required in understanding physical and functional networks of interacting DNA, noncoding RNAs including miRNAs, proteins and other molecules. As we are moving from a single key factor and reductionist methods to ‘cloud networks and motifs’ for understanding complex multifactorial diseases, similarly, the drug discovery pipeline is shifting into global inhibition of perturbed signaling transduction pathway networks.

Perspectives